Careers | CSL CSL was established in Australia in 1916 Over the ensuing years, CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases
Global Biotechnology Company | CSL Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St Gallen, Switzerland
Global Biotechnology Company | CSL CSL has delivered biotechnology excellence for over a century Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need
Global Biotechnology Company | CSL CSL Seqirus operates state-of-the-art manufacturing facilities on three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around the world
Professor Heimburger Award | CSL In his honor, CSL created the Heimburger Award to recognize the clinical and or preclinical research of emerging coagulation specialists who are driven to improve the care of patients with bleeding disorders
Global Biotechnology Company | CSL Our parent company, CSL, headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries
Worldwide Locations | CSL Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe
We Are CSL | CSL CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology
Our Businesses and Products | CSL CSL is committed to protecting public health and improving and saving the lives of patients with rare and serious diseases through the development, manufacture and reliable supply of high-quality medicines
Global Newsroom | CSL CSL Seqirus and Vaccine Industrial Company sign landmark Memorandum of Understanding with Ministry of Health to localize manufacturing of cell-based seasonal and pandemic influenza vaccines